Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
Fung
J J
JJ
Department of Surgery, University of Pittsburgh School of Medicine, PA.
Todo
S
S
Jain
A
A
McCauley
J
J
Alessiani
M
M
Scotti
C
C
Starzl
T E
TE
D000293:Adolescent; D000410:Alanine Transaminase / Q000097:blood; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003524:Cyclosporins / Q000009:adverse effects; D004341:Drug Evaluation; D005260:Female; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D007668:Kidney / Q000502:physiology; D008107:Liver Diseases / Q000175:diagnosis; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D016559:Tacrolimus
D000900:Anti-Bacterial Agents; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D016559:Tacrolimus